The Paris Bourse ended slightly down (-0.34%) on Wednesday, in a market on the defensive before a speech by President Emmanuel Macron, who is expected to announce new restrictive measures in the face of a worrying health situation.
The CAC 40 index gave up 20.81 points to finish at 6,067.23 points, ending five consecutive sessions in the green.
However, it ended the month of March with an increase of more than 6%, after an increase of 5.6% in February, which allowed it to return to its pre-pandemic levels at the end of February 2020.
The market has “crystallized quite a bit on the announcements expected this evening” in France, with globally “a health theme which prevails a little today” in Europe compared to the American markets, rather better oriented, summarized with by AFP Alexandre Baradez, analyst at IG France.
Closure of schools for a month, limited travel throughout the territory but no strict confinement: President Emmanuel Macron must decide against the third wave of Covid-19 and will announce it to the French at 8:00 p.m.
The trend is worrying in France, with more than 5,000 patients in intensive care, beyond the peak of the second wave in November, putting hospitals under very strong tension.
In addition, we must continue to “monitor rates in the United States, which have started to rise again in recent days,” adds Mr. Baradez.
The yield on the ten-year US Treasury bill stabilized on Wednesday around 1.71% after rising to nearly 1.77% the day before, a new high since the end of January 2020.
However, the president of the European Central Bank (ECB), Christine Lagarde, assured Wednesday that it will pass “some time” before the institution tightens its monetary policy, noting that inflationary pressures remain low in the euro area against the backdrop of the Covid-19 pandemic. Even if it increased in March to 1.3% over one year, after reaching 0.9% in January and February, inflation in the euro zone remains far from the target set by the ECB (close to 2%) .
For their part, consumer spending by French households remained stable in February over one month.
Voltalia withdraws from Burma
The French producer of renewable energies (-1.08% to 23.00 euros) will “put an end to its activities” in Burma, where the repression of the protest by the military junta in power has killed more than 520 people since the February 1, according to a statement released Wednesday.
Capgemini limits breakage
The French IT giant finished stable (+ 0.07% to 145.10 euros). It limited the impact of the health crisis in 2020, recording a decrease in its turnover of 3.2% at constant scope and exchange rates and a net profit up 12%, to 957 million euros .
Anticancer approved for Ipsen
The laboratory rose 4.50% to 73.15 euros after announcing Wednesday that the European Commission had approved its anticancer treatment Cabometyx, in combination with another Bristol-Myers Squibb molecule, for patients with carcinoma of the advanced kidney.
Get the latest news delivered to your inbox
Follow us on social media networks